Clinical Trial Participation

TargetCancer Foundation Announces Rare Cancer Precision Medicine Research Initiative | 8/16/2020

… communities. TRACK aims to provide the treatment care team with individualized treatment recommendations, informed by genomic analysis and in consultation with field-leading rare cancer clinicians and researchers. TRACK challenges the traditional paradigm of clinical trial participation by incorporating remote consent, enabling patients to access genomic information and tailored treatment recommendations without the typical requirement to travel to an academic medical center. TargetCancer Foundation, a patient-founded not-for-profit …

Pliant Therapeutics Provides Corporate Update and Announces Second-Quarter 2020 Financial Results | PR Newswire | 8/11/2020

… PSC) have resumed enrollment. Through close coordination with over 100 global trial sites, Pliant has continued to conduct site initiation activities throughout the COVID-19 pandemic. The Company is offering a hybrid approach to clinical trial participation with home-health solutions designed to minimize the requirements for visits to healthcare facilities, as well as a campaign to raise awareness of the IPF and PSC programs across patient communities and patient …

Follow Clinical Trial Participation:    

Medidata Congratulates ‘Tu Salud Tu Familia’ for Its Capital Emmy® Award | Business Wire | 8/10/2020

… today’s most pressing healthcare issues,” said Dr. Sandoval. “We are grateful to have Medidata’s support and partnership to amplify our message and to help improve our engagement with the community, including sharing information on clinical trial participation . We celebrate this wonderful Emmy Award recognition with them!” About Medidata Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights …

BBK Worldwide Creative Director, Patient Experience and Engagement, Jessica Kim Named to PharmaVOICE 100 | PR Newswire | 8/7/2020

… as well as text messaging, gamification, medication reminders, and content-rich podcasts. Recently, Ms. Kim helped spearhead Study-Life Balance – a new construct that leverages patient-centric solutions to help patients more easily integrate clinical trial participation into their daily lives. Study-Life Balance was inspired by today’s empowered healthcare consumer who has expectations for an enhanced healthcare journey. By putting clinical trial participation within the context of the patient’s …

Good but not good enough: Clinical trial participation of patients with myelodysplastic syndromes | 8/7/2020

Enter your email address below. Email or Customer ID Please check your email for instructions on resetting your password. If you do not receive an email within 10 minutes, your email address may not be registered, and you may need to create a new Wiley Online Library account. Request Username Can’t sign in? Forgot your username? Enter your email address below and we will send you your username Email or …

Precision Medicine Research Project Focuses on Rare Cancers | HealthIT Analytics | 8/6/2020

… announced the Target Rare Cancer Knowledge (TRACK) study, an initiative that leverages genomic analysis and precision medicine to provide patients and providers with personalized treatment recommendations. TRACK aims to challenge the traditional method of clinical trial participation by incorporating remote consent, allowing patients to access genomic information and tailored treatment recommendations without the requirement of traveling to an academic medical center. TargetCancer Foundation, a non-profit, patient-founded organization, will …

Informed consent approaches for clinical trial participation of infants with minor parents in sub-Saharan Africa: A systematic review | 8/4/2020

Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click here . Loading metrics Peer-reviewed Research Article Informed consent approaches for clinical trial participation of infants with minor parents in sub-Saharan Africa: A systematic review Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Visualization, Writing – original draft, Writing – review & editing E-mail: Affiliations Department of …

Digitizing clinical trials | 7/31/2020

… Current operational inefficiencies relating to the identification, recruitment, data acquisition, and follow-up of participants inflate costs, increase participant burden, and extend the already-long clinical trial timelines, all of which contribute to low clinical trial participation : for example, only about 8% of cancer patients enroll in cancer trials 1 , 2 . For people who do not live close to a research site or who have mobility or scheduling constraints, participating …

Jeffrey Koplan and Amelie Ramirez Join CDC Foundation Board of Directors | PR Newswire | 7/29/2020

… of the Department of Population Health Sciences and director of the Institute for Health Promotion Research. She has 30 years of experience conducting behavioral and communications projects to reduce cancer, increase screening rates and clinical trial participation , prove the efficacy of patient navigation for cancer patients, prevent tobacco use and improve healthy lifestyles among U.S. Latinos. She currently directs the Robert Wood Johnson Foundation-funded Salud America ! national multimedia program …

ASCO and ACCC Join Forces to Increase Participation of Racial and Ethnic Minority Populations in Cancer Treatment Trials | 7/21/2020

… trials to more fully reflect the diversity of people at risk for or living with cancer. The joint ASCO-ACCC initiative is designed to identify and implement novel strategies and practical solutions to increase clinical trial participation of racial and ethnic minority populations that continue to be underrepresented in cancer research when compared with their percentages in the overall population of patients with cancer. Recent analyses of cancer treatment trials …

ASCO & ACCC Join Forces to Increase Participation of Racial and Ethnic Minority Populations in Cancer Treatment Trials | 7/20/2020

… trials to more fully reflect the diversity of people at risk for or living with cancer. The joint ASCO-ACCC initiative is designed to identify and implement novel strategies and practical solutions to increase clinical trial participation of racial and ethnic minority populations that continue to be under-represented in cancer research when compared with their percentages in the overall population of patients with cancer. Recent analyses of cancer treatment …

Op-Ed: As COVID-19 Phase 3 Vaccine Studies Begin, We Must Improve Minority Participation in Clinical Trials | 6/29/2020

… autopsy material without their consent. In addition, sterilizing Native American women without their consent, and the infamous Tuskegee syphilis experiment, led to a justifiable fear and luck of trust by people of color regarding clinical trial participation in the U.S. Pictured: Dr. Asefa Mekonnen from Rockville,MD Recent publications have also indicated African Americans are overly represented in experimental and procedural studies that did not require informed consent. These are …

Minorities wanted for COVID-19 testing | 6/26/2020

… autopsy material without their consent. In addition, sterilizing Native American women without their consent, and the infamous Tuskegee syphilis experiment, led to a justifiable fear and luck of trust by people of color regarding clinical trial participation in the U.S. Recent publications have also indicated African Americans are overly represented in experimental and procedural studies that did not require informed consent. These are studies conducted under emergency situations when subjects …

COVID-19 ‘phase 3’ vaccine studies beginMinority participation in clinical trials must be improved | 6/26/2020

… autopsy material without their consent. In addition, sterilizing Native American women without their consent, and the infamous Tuskegee syphilis experiment, led to a justifiable fear and luck of trust by people of color regarding clinical trial participation in the U.S. Recent publications have also indicated African Americans are overly represented in experimental and procedural studies that did not require informed consent. These are studies conducted under emergency situations when subjects …

As COVID-19 Phase 3 Vaccine Studies Begin, We Must Improve Minority Participation in Clinical Trials - Savannah Tribune | 6/24/2020

… autopsy material without their consent. In addition, sterilizing Native American women without their consent, and the infamous Tuskegee syphilis experiment, led to a justifiable fear and luck of trust by people of color regarding clinical trial participation in the U.S. Recent publications have also indicated African Americans are overly represented in experimental and procedural studies that did not require informed consent. These are studies conducted under emergency situations when subjects …

Artificial Intelligence and Human Trust in Healthcare: Focus on Clinicians | 6/19/2020

… AI in Health Care AI has shown significant potential in the area of mining medical records, designing treatment plans [ 15 ], robotics mediated surgeries [ 16 ], medical management and supporting hospital operations, clinical data interpretation [ 17 ], clinical trial participation [ 18 , 19 ], image-based diagnosis [ 20 ], preliminary diagnosis [ 21 ], virtual nursing [ 22 ], and connected health care devices [ 23 ]. In addition to these applications, significant investments in AI research [ 24 ], as well as recent …

Dr. Asefa Jejaw Mekonnen: Op-Ed on COVID-19 Phase 3 Vaccine Studies at Tadias Magazine - Tadias Magazine | 6/19/2020

… autopsy material without their consent. In addition, sterilizing Native American women without their consent, and the infamous Tuskegee syphilis experiment, led to a justifiable fear and luck of trust by people of color regarding clinical trial participation in the U.S. Recent publications have also indicated African Americans are overly represented in experimental and procedural studies that did not require informed consent. These are studies conducted under emergency situations when subjects …

As COVID-19 Phase 3 vaccine studies begin, minority participation in clinical trials is crucial | 6/19/2020

… autopsy material without their consent. In addition, sterilizing Native American women without their consent, and the infamous Tuskegee syphilis experiment, led to a justifiable fear and luck of trust by people of color regarding clinical trial participation in the United States. Recent publications have also indicated African Americans are overly represented in experimental and procedural studies that did not require informed consent. These are studies conducted under emergency situations when …

As COVID-19 Phase 3 Vaccine Studies Begin, We Must Improve Minority Participation in Clinical Trials - Afro American | 6/17/2020

… autopsy material without their consent. In addition, sterilizing Native American women without their consent, and the infamous Tuskegee syphilis experiment, led to a justifiable fear and luck of trust by people of color regarding clinical trial participation in the U.S. Dr. Asefa Mekonnen is a Rockville, MD Recent publications have also indicated African Americans are overly represented in experimental and procedural studies that did not require informed consent. These are …

As COVID-19 Phase 3 Vaccine Studies Begin, We Must Improve Minority Participation In Clinical Trials - Scoop.co.nz | 6/17/2020

… autopsy material without their consent. In addition, sterilizing Native American women without their consent, and the infamous Tuskegee syphilis experiment, led to a justifiable fear and luck of trust by people of colour regarding clinical trial participation in the U.S. Recent publications have also indicated African Americans are overly represented in experimental and procedural studies that did not require informed consent. These are studies conducted under emergency situations when subjects …

Highlights of the BMC Series: May 2020 | 6/16/2020

… the best treatment for cancer provided within the context of a clinical trial. Through interviews and a systematic review of the literature, Nielsen et al . explored how physicians and nurses perceived the benefits of clinical trial participation and whether clinical trial participation provided better outcomes for cancer patients. Interviews revealed that there is a widespread belief amongst nurses and physicians that treatment for cancer, in the context of a clinical …

The MJFF and ESPN Founder Bill Rasmussen Target Trial Participation | 6/16/2020

… his signature upbeat attitude and commitment to staying active, Rasmussen hopes that by telling his story of Parkinson’s diagnosis and community engagement, he can encourage patients and families to help advance Parkinson’s study through clinical trial participation . He particularly hopes to involve the very newly diagnosed — those not yet on a Parkinson’s therapy — since they can help scientists track disease progression . He hopes to lead an effort to find, educate …

Pushing for More Ethnic and Racial Diversity in Clinical Trials | BioSpace | 6/12/2020

… of SU2C. “Now, more than ever, better understanding of the role of biology in cancer treatment, advances in precision treatment, and development of new technologies demands that we also make significant improvements in diverse clinical trial participation . We are confident that this initiative will make a significant and meaningful impact to ensure all communities have equal access to potentially life-saving treatments.” Underrepresentation This has been recognized as a problem …

Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian‐born versus migrant groups | 6/8/2020

Abstract Background/Aims This study compared rates of clinical trial participation and perceived adequacy of information provided prior to consent in migrant and Australian‐born cancer patients, and explored factors associated with being approached and agreeing to participate. Methods We utilized data from a larger cross‐sectional survey assessing disparities in patient‐reported outcomes in Chinese, Arabic, or Greek migrant versus English‐speaking Australian‐born cancer patients. Participants completed a …

In this issue | 6/8/2020

ORIGINAL ARTICLE Impact of migrancy on cancer clinical trial participation : Factors associated with approach and consent in Australian‐born versus migrant groups 28.2% of Australia’s estimated resident population (6.7 million) was born overseas. Lim et al. compared rates of clinical trial participation and perceived adequacy of information provided prior to consent in migrant and Australian‐born cancer patients, and explored factors associated with being approached and agreeing to participate and …

Clinical Research

Medidata Congratulates ‘Tu Salud Tu Familia’ for Its Capital Emmy® Award | Business Wire | 8/10/2020

… importance of different health issues. It was created and is hosted by Dr. Fabian Sandoval, CEO and Medical Director, Emerson Clinical Research Institute. Medidata, along with Genentech, has been sponsoring the program since its inception … improve our engagement with the community, including sharing information on clinical trial participation. We celebrate this wonderful Emmy Award recognition with them!” About Medidata Medidata is leading the digital transformation of life sciences, creating hope …

Food and Drug Administration

Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers | BMJ | 3/16/2020

… could provide a treatment option for medication that would otherwise be unavailable—whether due to not being approved by the Food and Drug Administration (FDA), not approved for the indication of SLE or not affordable … experienced) Patients were equally proactive in discussing the disadvantages of clinical trial participation. Participants were particularly concerned about the unknown aspects of clinical trial participation, especially the outcome and side effects experienced. For newer therapies …

Medicaid

Calculating the Costs of Clinical Trials | 12/1/2019

… the trial ends. ASH Clinical News recently spoke with several clinical trial and ethics experts about the hidden costs of clinical trial participation, the prices of post-trial access to investigational drugs, and some of … requirements that clinical trials must meet to qualify.) Coverage through Medicaid varies on a state-by-state basis, however, and defining “routine care” can be a bit of a gray area. “If you are enrolled …

Medicare

Calculating the Costs of Clinical Trials | 12/1/2019

… the trial ends. ASH Clinical News recently spoke with several clinical trial and ethics experts about the hidden costs of clinical trial participation, the prices of post-trial access to investigational drugs, and some of … with participation in the trial.” 4 Private insurance companies and Medicare must cover routine patient costs for qualifying clinical trials. (See SIDEBAR on page 48 for the long list of requirements that clinical trials must …

NIH

Calculating the Costs of Clinical Trials | 12/1/2019

… trial participation Of the three potential risks of participating in a clinical trial listed on the National Institutes of Health (NIH) website, two are related to the potential costs, hidden and otherwise: People who participate … clinical trial and ethics experts about the hidden costs of clinical trial participation, the prices of post-trial access to investigational drugs, and some of the steps being taken to ease this burden. What’s Covered …

National Institutes of Health

Calculating the Costs of Clinical Trials | 12/1/2019

… the hidden costs of trial participation Of the three potential risks of participating in a clinical trial listed on the National Institutes of Health (NIH) website, two are related to the potential costs, hidden and … clinical trial and ethics experts about the hidden costs of clinical trial participation, the prices of post-trial access to investigational drugs, and some of the steps being taken to ease this burden. What’s Covered …

Patient Safety

(USA-OH-Columbus) Clinical Research Coordinator RN NE - RI Translational B | 11/19/2019

… Research Nurse (CRN) prescribes, delegates, supervises and provides patient care, plans for education, collaborates on care plans and provides for patient safety and quality while the patient is involved in the clinical research trial. In … Documents a plan of care including patient outcome parameters throughout clinical trial participation including but not limited to: a. Works with study physician and other ancillary service providers to ensure all protocol required procedures are …

Patient Recruitment

Protocol for a mixed-methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) randomised control trial | BMJ | 11/13/2019

… use. The recruitment and retention strategies under investigation in this feasibility study build on existing research on incentivising and improving clinical trial participation among people who use opioids. 29 30 (See figure 1 : study schematic … rapport and build trust, which has been shown to improve patient recruitment and retention. 30 All staff have received anti-oppression training. Wherever possible, the same SOONER staff person who conducts informed consent and recruits …

American College of Rheumatology

Genentechs Gazyva (obinutuzumab), in Combination With Standard of Care, More Than Doubles the Percentage of Lupus Nephritis Patients Achieving Complete Renal Response, Compared To Standard of Care Alone | 11/10/2019

… infections (6% vs.18% in placebo group) were not increased with Gazyva. These data will be presented at the 2019 American College of Rheumatology (ACR) Annual Meeting in Atlanta, Georgia, on November 10, 2019 (Abstract … to get lupus. Genentech is committed to addressing barriers to clinical trial participation and advancing inclusive research to create new standards for clinical studies. Genentech is taking action to recruit a broader, more diverse population …

National Cancer Institute

Sex disparities ‘pervasive’ in cancer clinical trial participation | 10/15/2019

Sex-based disparities remain pervasive in cancer clinical trial participation, according to results of a retrospective meta-analysis published in Journal of the National Cancer Institute. Researchers observed underrepresentation of women primarily in noncooperative-group-supported trials, which account for the majority of randomized controlled trials. “In totality, we tried to mirror how other studies have been modeled to give an update on what disparities in clinical trials look like …

Clinical Data

Helping Cancer Patients Navigate Clinical Trials | BioSpace | 10/15/2019

… ovarian cancer patient, talks about the need for clinical trial navigators and offers a unique perspective on battling cancer and clinical trial participation. Challenges with clinical trial participation Fewer than 5% of adults with cancer … best control data parameters to make data analysis less messy. Clinical data is usually more complex than preclinical data, so researchers try to control some variables by imposing these criteria. However, controlling research data parameters …

Clinical Trial Recruitment

Cancer patients often need this one basic thing to participate in clinical trials | 10/11/2019

… clinical trial participation: finding a suitable study and paying out-of-pocket costs, such as transportation and lodging. But Dornsife now has a more ambitious crusade, one that aims to do nothing less than change the status quo. “The goal,” says the Lazarex website, “is to permanently fix the clinical trial recruitment system by shifting the financial burden of participation from the patient to the pharmaceutical companies who need patients …

Centers for Medicare and Medicaid Services

UsAgainstAlzheimer’s Applauds the Bipartisan Introduction of the CHANGE Act, Critical Legislation to Promote Early Diagnosis of Alzheimer’s | PR Newswire | 4/10/2019

Centers for Medicare and Medicaid Services (CMS) to require the use of cognitive impairment detection tools identified by the National Institutes of Health. The bill would also direct CMS to incentivize the detection and diagnosis of Alzheimer’s disease or related dementias and promote care planning services, including potential for clinical trial participation, which have historically had low levels of engagement, particularly among communities of color. “I thank this bipartisan group …

Genentech

Medidata Congratulates ‘Tu Salud Tu Familia’ for Its Capital Emmy® Award | Business Wire | 8/10/2020

… was created and is hosted by Dr. Fabian Sandoval, CEO and Medical Director, Emerson Clinical Research Institute. Medidata, along with Genentech, has been sponsoring the program since its inception in 2019, recognizing the importance of … improve our engagement with the community, including sharing information on clinical trial participation. We celebrate this wonderful Emmy Award recognition with them!” About Medidata Medidata is leading the digital transformation of life sciences, creating hope …

Medidata Congratulates ‘Tu Salud Tu Familia’ for Its Capital Emmy® Award | Business Wire | 8/10/2020

… was created and is hosted by Dr. Fabian Sandoval, CEO and Medical Director, Emerson Clinical Research Institute. Medidata, along with Genentech, has been sponsoring the program since its inception in 2019, recognizing the importance of … improve our engagement with the community, including sharing information on clinical trial participation. We celebrate this wonderful Emmy Award recognition with them!” About Medidata Medidata is leading the digital transformation of life sciences, creating hope …

Biogen

Genentech’s Gazyva (obinutuzumab), in Combination With Standard of Care, More Than Doubles the Percentage of Lupus Nephritis Patients Achieving Complete Renal Response, Compared to Standard of Care Alone - Valdosta Daily Times | Business Wire | 11/9/2019

… are two to three times more likely than Caucasian women to get lupus. Genentech is committed to addressing barriers to clinical trial participation and advancing inclusive research to create new standards for clinical studies. Genentech … system. Gazyva is part of a collaboration between Genentech and Biogen. Combination studies investigating Gazyva with other approved or investigational medicines, including cancer immunotherapies and small molecule inhibitors, are underway across a range of blood …

Genentech’s Gazyva (obinutuzumab), in Combination With Standard of Care, More Than Doubles the Percentage of Lupus Nephritis Patients Achieving Complete Renal Response, Compared to Standard of Care Alone | Business Wire | 11/9/2019

… are two to three times more likely than Caucasian women to get lupus. Genentech is committed to addressing barriers to clinical trial participation and advancing inclusive research to create new standards for clinical studies. Genentech … system. Gazyva is part of a collaboration between Genentech and Biogen. Combination studies investigating Gazyva with other approved or investigational medicines, including cancer immunotherapies and small molecule inhibitors, are underway across a range of blood …

Pfizer

LRA Applauds Exciting Lupus Research Being Presented at 2019 ACR/ARP Annual Meeting | PR Newswire | 11/7/2019

… 8-13, 2019 . In addition, results of two positive clinical studies conducted by LRA’s affiliate Lupus Therapeutics (LT) in collaboration with Pfizer and the Rilite Foundation focus on improving how lupus disease activity is monitored. The … with lupus and family members can work collaboratively to accelerate clinical trial participation in lupus and drug discovery. About Lupus Lupus is a chronic, complex autoimmune disease that affects millions of people worldwide. More than …

Cancer patients often need this one basic thing to participate in clinical trials | 10/11/2019

… later, the Flourtown retiree, 67, is going strong, thanks to participating in clinical testing of a targeted drug developed by Pfizer. Lorbrena was approved last November, and it is still keeping Bagga’s cancer at bay … than 4,000 cancer patients overcome the well-documented barriers to clinical trial participation: finding a suitable study and paying out-of-pocket costs, such as transportation and lodging. But Dornsife now has a more ambitious …

MD Anderson Cancer Center

Precision Medicine Research Project Focuses on Rare Cancers | HealthIT Analytics | 8/6/2020

… and precision medicine to provide patients and providers with personalized treatment recommendations. TRACK aims to challenge the traditional method of clinical trial participation by incorporating remote consent, allowing patients to access genomic information and tailored … The University of California San Diego and University of Texas MD Anderson Cancer Center will serve as enrolling sites for the study. Participants will also have the option to enroll remotely in the study with …

Sex disparities ‘pervasive’ in cancer clinical trial participation | 10/15/2019

Sex-based disparities remain pervasive in cancer clinical trial participation, according to results of a retrospective meta-analysis published in Journal of the National Cancer Institute. Researchers observed underrepresentation of women primarily in noncooperative-group … Ludmir, MD, resident radiation oncologist at The University of Texas MD Anderson Cancer Center, told HemOnc Today . “It’s hard to exactly assess the impact of these disparities on clinical research. When we run these clinical …

The University of Texas MD Anderson Cancer Center

Sex disparities ‘pervasive’ in cancer clinical trial participation | 10/15/2019

Sex-based disparities remain pervasive in cancer clinical trial participation, according to results of a retrospective meta-analysis published in Journal of the National Cancer Institute. Researchers observed underrepresentation of women primarily in noncooperative-group … in cancer,” Ethan B. Ludmir, MD, resident radiation oncologist at The University of Texas MD Anderson Cancer Center, told HemOnc Today . “It’s hard to exactly assess the impact of these disparities on clinical research. When …

New Patient Resource from NCCN Helps People with Bladder Cancer Make Informed Treatment Decisions | Markets Insider | Business Insider | 6/26/2019

… to take notes. “There have been five new drug approvals for bladder cancer in the last few years, and increasing clinical trial participation has been key to these advances. We’ve definitely turned a corner, and … CO ; University of Michigan Rogel Cancer Center, Ann Arbor, MI ; The University of Texas MD Anderson Cancer Center, Houston, TX ; University of Wisconsin Carbone Cancer Center, Madison, WI ; Vanderbilt-Ingram Cancer Center, Nashville, TN ; and …

Mayo Clinic

New Patient Resource from NCCN Helps People with Bladder Cancer Make Informed Treatment Decisions | PR Newswire | 6/26/2019

… to take notes. “There have been five new drug approvals for bladder cancer in the last few years, and increasing clinical trial participation has been key to these advances. We’ve definitely turned a corner, and … H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL …

CISCRP’s Free Community Health Event Coming to Jacksonville, FL | PRWeb | 11/22/2017

… will interact with local researchers, clinical trial participants, health care professionals, and advocacy groups, to learn about clinical research and clinical trial participation. Attendees will also have access to health screenings, including blood pressure, BMI … hope to patients,” says Charles Burger, M.D., professor of medicine, Mayo Clinic College of Medicine and Science, and keynote speaker. “At Mayo Clinic, the true purpose of research is to address the unmet needs of …

Levi Garraway

Genentechs Gazyva (obinutuzumab), in Combination With Standard of Care, More Than Doubles the Percentage of Lupus Nephritis Patients Achieving Complete Renal Response, Compared To Standard of Care Alone | 11/10/2019

… proliferative lupus nephritis; a condition for which there is a strong need for more effective and targeted treatment options, ” said Levi Garraway, M.D., Ph.D., chief medical officer and head of Global Product Development. “These results … to get lupus. Genentech is committed to addressing barriers to clinical trial participation and advancing inclusive research to create new standards for clinical studies. Genentech is taking action to recruit a broader, more diverse population …

Genentech’s Gazyva (obinutuzumab), in Combination With Standard of Care, More Than Doubles the Percentage of Lupus Nephritis Patients Achieving Complete Renal Response, Compared to Standard of Care Alone – Company Announcement - FT.com | Financial Times | 11/9/2019

… proliferative lupus nephritis; a condition for which there is a strong need for more effective and targeted treatment options,” said Levi Garraway , M.D., Ph.D., chief medical officer and head of Global Product Development. “These results … to get lupus. Genentech is committed to addressing barriers to clinical trial participation and advancing inclusive research to create new standards for clinical studies. Genentech is taking action to recruit a broader, more diverse population …

Sandra Horning

FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab) in Lupus Nephritis – Company Announcement - FT.com | Financial Times | 9/18/2019

… options are needed for lupus nephritis, a potentially life-threatening inflammation of the kidneys that most commonly affects women,” said Sandra Horning , M.D., chief medical officer and head of Global Product Development. “We are committed … to get lupus. Genentech is committed to addressing barriers to clinical trial participation and advancing inclusive research to create new standards for clinical studies. Genentech is taking action to recruit a broader, more diverse population …

FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab) in Lupus Nephritis | Business & Finance | heraldchronicle.com | Business Wire | 9/18/2019

… options are needed for lupus nephritis, a potentially life-threatening inflammation of the kidneys that most commonly affects women,” said Sandra Horning, M.D., chief medical officer and head of Global Product Development. “We are committed … to get lupus. Genentech is committed to addressing barriers to clinical trial participation and advancing inclusive research to create new standards for clinical studies. Genentech is taking action to recruit a broader, more diverse population …